Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Southeastern Asset Management Inc. TN

Southeastern Asset Management Inc. TN increased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 52.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,131,084 shares of the company’s stock after buying an additional 1,073,359 shares during the period. Oscar Health makes up about 2.0% of Southeastern Asset Management Inc. TN’s investment portfolio, making the stock its 20th biggest position. Southeastern Asset Management Inc. TN’s holdings in Oscar Health were worth $42,082,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock worth $255,333,000 after buying an additional 586,626 shares during the period. Deerfield Management Company L.P. Series C increased its stake in Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after buying an additional 3,983,325 shares during the period. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after buying an additional 8,051,379 shares during the period. Gilder Gagnon Howe & Co. LLC increased its stake in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after buying an additional 2,151,256 shares during the period. Finally, BIT Capital GmbH increased its stake in Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after buying an additional 4,396,872 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 24.39% of the company’s stock.

Oscar Health Price Performance

OSCR opened at $16.56 on Friday. The company has a 50-day moving average of $13.40 and a 200-day moving average of $14.65. The company has a market capitalization of $4.15 billion, a P/E ratio of -827.59 and a beta of 1.75. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company’s revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.62 EPS. Equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.